TREPROSTINIL(REMODULIN) Treatment For Pulmonary Hypertension CAS 81846-19-7

Basic Info

Model No.: 81846-19-7

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Product Description

TREPROSTINIL is also known as REMODULIN .CAS Number 81846-19-7. For the treatment of pulmonary hypertension, pulmonary hypertension is a class of known or unknown causes of abnormal pulmonary artery pressure rise in the disease or pathophysiology syndrome to pulmonary arterial vasospasm, intimal hyperplasia, middle hypertrophy, the outer membrane Hyperplasia, in situ thrombosis, varying degrees of inflammation and plexiform changes are characterized by clinical manifestations of pulmonary arterial pressure increased and eventually lead to right heart failure. TREPROSTINIL CAS 81846-19-7 has been proved to be a clinically effective and safe product. Its injection for the treatment of pulmonary hypertension is one of the effective injection of the preparation of good stability, long half-life, mainly using subcutaneous continuous infusion mode of administration, but also sustainable intravenous infusion, subcutaneous route of administration is relatively safe, Can reduce the risk of severe infection sepsis.

Thera. Category: Pulmonary Hypertension Treatment

Cas No.: 81846-19-7

Synonym:REMODULIN;TREPROSTINIL;U 62840; UT-15

Molecular Formula:C23H34O5

Molecular Weight:390.51           

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:  treatment of pulmonary hypertension